Artificial Intelligence

New machine-learning method makes computer simulations of atoms faster and more efficient

January 3, 2025
By Veronica Bartell | College of Chemistry
Researchers have created a new machine-learning method called EScAIP that makes simulations of atoms faster and more efficient.

UC Berkeley scientists collaborate with Merck KGaA, Darmstadt, Germany on catalyst digital design program

May 31, 2023
UC Berkeley, College of Chemistry Press Release
Merck KGaA, Darmstadt, Germany, a leading science and technology company, has today announced a three-year collaboration with the research group of John Hartwig at UC Berkeley and Lawrence Berkeley National Laboratory.

Teresa Head-Gordon receives COVID-19 research funding

June 25, 2020
UC Berkeley, College of Chemistry Press Release
Teresa Head-Gordon, Chancellor's Professor of Chemistry, Bioengineering, and Chemical and Biomolecular Engineering, joins three colleagues from Berkeley Engineering who have received funding from the C3.ai Digital Transformation Institute for COVID-19 projects.

Three decades after UN milestone, experts convene to find AI climate solutions

March 21, 2024
By Rachel Leven | Berkeley Computing, Data Science, and Society
Aditi Krishnapriyan, Omar Yaghi, and colleagues are using the power of artificial intelligence to develop cutting-edge technology to stem the planet’s warming and its related impacts.

Markita Landry receives 2018 DARPA Young Faculty Award

July 18, 2018
Assistant Professor of Chemical and Biomolecular Engineering Markita Landry has been awarded a prestigious two-year Department Of Defense Advanced Research Projects Agency (DARPA) Young Faculty Award for her project Brain Chemical Signaling: A New Input Signal for Brain-Computer Interfaces.

Molecular Sciences Software Institute launches open-source data sharing project for COVID-19

May 26, 2020
Virginia Tech Press release
The Molecular Sciences Software Institute has launched an open-source website that will allow biomolecular scientists from around the world to share computer-aided drug-testing simulations targeting the protein at the center of COVID-19.